Bobby Liaw, MD

Clinical Focus

• Adrenal Gland Tumors
• Bladder Cancer
• Genitourinary Malignancies
• Kidney Cancer
• Prostate Cancer
• Renal Cancer
• Sarcomas
• Sarcomas, Soft-Tissue
• Testicular Tumors

• Adrenal Gland Tumors
• Bladder Cancer
• Genitourinary Malignancies
• Kidney Cancer
• Prostate Cancer
• Renal Cancer
• Sarcomas
• Sarcomas, Soft-Tissue
• Testicular Tumors

Research

Locations

The Blavatnik Family – Chelsea Medical Center

325 West 15th Street, 1st Floor, (between 8th and 9th Avenues), New York, NY, 10011

212-604-6010

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Healthfirst Medicare Advantage insurance: Effective 9/1/2024, Mount Sinai’s primary care providers (internal medicine, family practice, and geriatrics) are not accepting new Healthfirst Medicare patients. Please contact Healthfirst for help finding a primary care provider. Healthfirst Medicare members who have a relationship with a Mount Sinai primary care provider can continue to book appointments with them.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Zakaria Chakrani, Mann Patel, George Mellgard, Stephen McCroskery, Nathaniel Saffran, Nicole Taylor, Bobby C. Liaw, Matthew Galsky, William Oh, Che Kai Tsao, Teja Ganta, Vaibhav Patel. Clinical Genitourinary Cancer
• Performance Status and End-of-Life Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Androgen Receptor Targeted Therapy. George Mellgard, Nathaniel Saffran, Zakaria Chakrani, Stephen McCroskery, Nicole Taylor, Mann Patel, Bobby Liaw, Matthew Galsky, William Oh, Che Kai Tsao, Vaibhav Patel. American Journal of Clinical Oncology: Cancer Clinical Trials
• Risk Factors for Early Treatment Discontinuation Due to Toxicity among Patients with Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy. Zakaria Chakrani, George Mellgard, Nathaniel Saffran, Stephen McCroskery, Nicole Taylor, Mann Patel, Bobby Liaw, Matthew Galsky, William K. Oh, Che Kai Tsao, Vaibhav G. Patel. American Journal of Clinical Oncology: Cancer Clinical Trials

Industry Relationships